Greg Moeck

Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections

G. Ralph Corey, Heidi Kabler, Purvi Mehra et al. · New England Journal of Medicine · 2014 · 296 citations · Full text

Antimicrobial drug discovery through bacteriophage genomics

Jing Liu, Mohammed Dehbi, Greg Moeck et al. · Nature Biotechnology · 2004 · 233 citations

Antimicrobial Drug Discovery, Antibiotics, Bacteriophage +7

Single-Dose Oritavancin Versus 7–10 Days of Vancomycin in the Treatment of Gram-Positive Acute Bacterial Skin and Skin Structure Infections: The SOLO II Noninferiority Study

G. Ralph Corey, Samantha Good, Hai Jiang et al. · Clinical Infectious Diseases · 2014 · 213 citations · Full text

VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in <i>Enterobacterales</i> and Pseudomonas aeruginosa

Jodie C. Hamrick, Jean‐Denis Docquier, Tsuyoshi Uehara et al. · Antimicrobial Agents and Chemotherapy · 2019 · 204 citations · Full text

Oritavancin Kills Stationary-Phase and Biofilm<i>Staphylococcus aureus</i>Cells In Vitro

Adam Belley, Eve Neesham-Grenon, Geoffrey A. McKay et al. · Antimicrobial Agents and Chemotherapy · 2008 · 173 citations · Full text

Antimicrobial Susceptibility, Antibiotics, Microbial Pathogens +14